There are 2789 resources available
1532P - Fusion and rearrangement (RE) detection using DNA and RNA-based comprehensive genomic profiling (CGP) of sarcomas
Presenter: Kristin Ganjoo
Session: ePoster Display
1464P - Clinical factors associated with survival time from the last administration of systemic anticancer therapy to death in patients with advanced cancer
Presenter: Shuji Hiramoto
Session: ePoster Display
1465P - Exploring the spiritual needs of palliative care patients and their caregivers
Presenter: Sultan Kav
Session: ePoster Display
1466P - Napabucasin + nab-paclitaxel with gemcitabine in patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC): Results from the phase III CanStem111P study
Presenter: Tanios Bekaii-Saab
Session: ePoster Display
1467P - POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Dirk Arnold
Session: ePoster Display
1468P - POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Talia Golan
Session: ePoster Display
1470P - Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence
Presenter: Thatcher Heumann
Session: ePoster Display
1471P - Overall survival by BRCA and ATM mutation status in patients with metastatic pancreatic cancer: Findings from the PRIOR-2 study
Presenter: Gboyega Adeboyeje
Session: ePoster Display
1472P - Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of response to first-line therapy: The KRASCIPANC study
Presenter: Camille Evrard
Session: ePoster Display
1473P - Gender differences in treatment allocation and survival in a real-world metastatic pancreatic cancer cohort
Presenter: Esther Pijnappel
Session: ePoster Display